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Abstract
Background: Hepatocellular Carcinoma (HCC) is a common malignancy worldwide with a high burden in West Africa. Male
to female ratios show consistent bias toward males, the biological bases and variations of which are not well understood.
We have used data from the Gambian National Cancer Registry to compare trends in incidence of HCC in both genders.
Methods and Findings: Two periods were compared, 1988–1997 (early) and 1998–2006 (recent). In addition, the regression
program joinpoint was used to assess trends over 19 years. Differences with self-reported ethnicity were assessed for the
recent period using population data from 2003 census. Male to female ratio showed a significant decrease between the two
periods from 3.28:1 (95% CI, [2.93–3.65]) to 2.2:1 (95% CI, [1.99–2.43]). Although rates in males were relatively stable (38.36
and 32.84 for, respectively, early and recent periods), they increased from 11.71 to 14.9 in females with a significant Annual
Percentage Change of 3.01 [0.3–5.8] over 19 years and an increase in number of cases of 80.28% (compared to 26% in
males). Significant variations in HCC risk, but not in gender ratio were observed in relation with ethnicity.
Conclusion: This analysis of the only national, population-based cancer registry in West Africa shows a significant increase in
HCC in females over recent years. This increase may be the consequence of major changes in lifestyle or viral risk factors, in
particular obesity and hepatitis C, which have both been documented to increase in West Africa during recent years.
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Introduction
The Gambia is the smallest country of continental Africa and its
population comprises diverse different ethnic groups also present
in other countries of West Africa. It is the only African country
with population-based, nationwide cancer registration (The
Gambia National Cancer Registry). The Gambia National Cancer
Registry was established in 1986 in the framework of the Gambia
Hepatitis Intervention Study (GHIS) to provide data on the
incidence of all cancers, with particular emphasis on liver cancer,
the end-point of GHIS. The GHIS is a collaborative project
between the Government of The Gambia, the International
Agency for Research on Cancer, and the Medical Research
Council of the United Kingdom. Its aim is to evaluate the
protective effectiveness of hepatitis B vaccination in childhood
against chronic liver disease, namely cirrhosis and primary liver
cancer, in adulthood [1]. Worldwide, liver cancer is the sixth most
common cancer estimated for the year 2002, with over 80% of all
cases occurring in low resource and emerging countries [2]. The
male to female ratio shows a consistent bias toward males, varying
between 4:1 and 2:1, depending upon geographic area [3].
Although this male to female discrepancy is not completely
understood, several explanations have been proposed such as the
impact of alcohol consumption, cigarette smoking, higher levels of
hepatic iron, higher risk of infection by Hepatitis B Virus or
Hepatitis C Virus in men as compared to women and differential
effects of androgens on the proliferation of hepatocellular
carcinoma cells [3,4]. In West Africa and in The Gambia in
particular, liver cancer (hepatocellular carcinoma) is by far the
most common cancer among men and the second among women
(after cervix cancer) with a male to female ratio of about 3.18:1
[5,6]. In contrast to western countries, alcohol consumption and
cigarette smoking are negligible risk factors in The Gambia [7–9].
Well-known risk factors for hepatocellular carcinoma in this region
are exposure to dietary aflatoxin combined to chronic Hepatitis B
Virus and/or Hepatitis C Virus infection. Data from a case-
control study indicate that the prevalence of chronic hepatitis
carriage in healthy adults in The Gambia is 15.6% for Hepatitis B
Virus and 2.7% for Hepatitis C Virus [10]. In this study, we have
used data from the Gambia National Cancer Registry to assess the
variations in liver cancer incidence in relation with age, gender,
and ethnicity, three variables registered in the Gambia National
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periods, 1988–1997 and 1998–2006.
Results
Liver cancer incidence
Over the past 19 years (1988–2006) the Gambia National Cancer
Registry recorded a total of 2975 cases of liver cancer, including
2179 in males and 796 in females. Incidence data over the first 10
years of registration (1988–1997) have been previously reported [6].
Recent data (1998–2006) confirmed these earlier observations.
Overall, cancer incidences were very low in both genders. Liver
cancer wasthe most frequent cancer, representing62% of all cancer
cases among men recorded in the Gambia National Cancer
Registry, with an Age standardized rate (ASR) of 32.84 (95% CI,
[30.97–34.70]) per 10
5 person-years. In women, it represented 28%
of all cancers, with an ASR of 14.90 (95% CI, [13.62–16.17]) per
10
5 person-years, and ranking second most common cancer after
cervix cancer (15.45 (95% CI, [14.18–16.66]) per 10
5 person-years)
(Table 1). The main basis for diagnosis was clinical observation.
Only a minority of cases was assessed by ultrasonography (40% of
cases for the recent period) and levels of alpha foetoprotein
(.100 ng/ml; measured on average in 33% for women and 42%
for men) (Table S1). Histopathological confirmation of diagnosis
was not available dueto ethical and clinical restrictionson obtaining
liver biopsies from patients with advanced liver cancer. HBsAg
status was known for less than 30% of the patients among which
54.2% and 36.6% werepositive for HBsAgamong men and women
respectively. The mean age at diagnosis was 46 years for women
and 45 years for men.
Liver cancer trends
The liver cancer burden curves by age group showed a
progressive increase with age in both men and women.
Nevertheless, compared to men, the increase in incidence rates
was slower and more progressive among women, who showed
rates on average 2 fold lower compared to men (Figure 1).
Comparing the early period (1988–1997) to the recent one (1998–
2006), the male to female ratio showed a decrease of 33%, from
3.28:1 (95% CI, [2.93–3.65]) to 2.2:1 (95% CI, [1.99–2.43])
respectively. Indeed, from the period 1988–1997 to 1998–2006,
the ASR among men has slightly decreased from 38.36 to 32.84
(ASR ratio 0.86 95% CI, [0.79–0.93]), while among women, it has
increased from 11.71 to 14.90 for the early and recent period
respectively (ASR ratio 1.27 95% CI, [1.12–1.45]) (Table 2).
The cumulative curves by age group for men and women
(Figures 2, 3), comparing the rate by age group for the two periods
(recent to early) showed a small decrease of rate among men in
particular after the age group 30–34 while among women, there
was a clear increase of rate in all age groups. When comparing
each year of the two periods (Figures S1, S2), the incidence rates
for men were relatively stable with a decrease in years 2000–2005
and a modest increase in 2006. In contrast, the cumulative rates
for women showed an increase in rates for all years of the recent
period. However, the lowest increase was observed for years 2001–
2003, concordant with the decrease observed in men. This effect
might reflect a change in liver cancer detection strategies that
resulted in under ascertainment of liver cancers, principally in
older age groups, in the years 2001–2005, and which was
corrected in more recent years. This effect is obvious in males,
but is less visible in females, in whom it is largely compensated by
an increase in all age groups. Using joinpoint regression program
over the past 19 years (1988–2006), the slope for men presented a
non-significant annual percentage change (APC) of 0.02 [21.8;
1.9] (Pvalue =0.980). The apparent discrepancy between this
joinpoint analysis and the modest decrease shown in Table 2 and
Figure 2a may be explained by the rather wide dispersion of
annual data points. In contrast, among women, the joinpoint
regression shows a significant APC of 3.01 [0.3; 5.8] (P value
=0.028) (Figures S3, S4).
Table 1. Most common cancers in The Gambia for the period 1998–2006.
Men Women
Site
Total Number of
cases ASR (w) per 100000
%o fa l l
cancers Total number ASR (w) per 100000
%o fa l l
cancers
Oesophagus 17 0,55 0,87 14 0,51 0,76
Stomach 48 1,58 2,45 17 0,59 0,92
Colorectal, Anus 40 1,17 2,04 28 0,93 1,51
Liver 1215 32,84 61,99 512 14,90 27,69
Pancreas 22 0,73 1,12 13 0,51 0,70
Trachea, bronchus and lung 71 2,46 3,62 10 0,39 0,54
Kaposi sarcoma 21 0,51 1,07 9 0,20 0,49
Soft tissues 25 0,60 1,28 32 0,94 1,73
Breast 11 0,35 0,56 215 5,82 11,63
Cervix - - - 545 15,45 29,48
Corpus uteri - - - 31 0,92 1,68
Ovary - - - 36 0,97 1,95
Prostate 95 3,46 4,85 - - -
Bladder 29 0,91 1,48 8 0,21 0,43
Thyroid 11 0,25 0,56 36 0,90 1,95
Non-Hodgkin lymphoma 88 1,42 4,49 67 1,29 3,62
doi:10.1371/journal.pone.0018415.t001
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There were significant differences among ethnic groups in the
relative risk of liver cancer for the period 1998–2006. Considering
the Mandinka (most numerous group) as reference, the Fula and
Wollof had respectively a significantly higher risk of 2.15 (95% CI,
[1.83–2.53]) and 1.78 (95% CI, [1.50–2.10]) in men. In contrast,
the Serrahuleh had a lower significant risk (0.61, 95% CI, [0.44–
0.84]). Among women, the Fula and Wollof had a significant
higher risk of 1.94 (95% CI, [1.51–2.48]) and 1.80 (95% CI,
[1.38–2.35]) as compared to the Mandinka (Table 3). After
adjustment for district of residence, the Wollof presented the
highest significant risk in both genders (1.55 (95% CI, [1.31–1.84),
and 1.37 (95% CI, [1.05–1.79) in male and female respectively, as
compared to Mandinka. In Fula, a significantly increased risk of
1.40 (95% CI, [1.20–1.65]) was observed in males, whereas it was
only slightly and non-significantly increased in females (1.22 (95%
CI, [0.95–1.79)) (Table 3). Table S2 shows unadjusted rate ratios
in relation with division of residence and the proportion of
different ethnic groups in the population of each division,
respectively.
Discussion
Despite the fact that liver cancer is the main form of cancer in
West Africa, there is little information available on its variations
with age, time, gender and ethnicity. The Gambian National
Cancer Registry has collected structured, nationwide information
on liver cancer since 1986. One of the limitations of the data
collected by the registry is the paucity of diagnostic information,
with only about 40% of the cases assessed by liver ultrasonography.
However, the diagnosis of liver cancer is unlikely to be strongly
biased by other, space-filling liver lesions. A recent study of 323
clinically assessed cases from The Gambia showed that over 90% of
the cases presented with very advanced liver cancer, 45% of them
having tumors with a diameter over 10 cm. More than two-third
had multiple lesions and 41% had lesions in both liver lobes. The
main clinical features were hepatomegaly (92%), abdominal pain
(94%) and weight loss (94%). This triad was present in 74% of the
patients and the median duration of reported symptoms prior to
HCC diagnosis was 8 weeks [11]. Furthermore, only 67% of the
cases showed evidence of cirrhosis at the time of HCC diagnosis. A
morphological study of 35 liver biopsies obtained in the course of a
case-control study confirmed HCC in 29 (83.3%) of patients having
been diagnosed only on the basis of clinical criteria. The 6 excluded
cases were 1 liver hemangioma and 5 liver metastases of unspecified
primary tumors. The specificity increased to 95% using the
combination of clinical assessment, a-foetoprotein levels and
ultrasonography [12]. Of note, cases of liver metastases of identified
primary tumors were excluded from the present analysis.
Analysis of liver cancer incidence data over two time periods of
registration (1988–1997and1998–2006)hasallowedustodrawtwo
main observations. First, between the two periods, there has been a
decrease in male to female ratio (from 3.28to 2.20, 233%), and this
decrease is essentially attributable to an increase in femalesin all age
Figure 1. Liver cancer incidence rates per 100000 Gambians by 5-years age groups. Data from the Gambia National Cancer Registry, 1998–
2006.
doi:10.1371/journal.pone.0018415.g001
Table 2. Comparison of the ASRs evolution by gender for the period 1988–1997 and 1998–2006.
1988–1997 1998–2006 Evolution
Cases ASRs 95% Cis Cases ASRs 95% Cis Cases ASR Ratio 95% Cis
Male 964 38.36 36.16–40.56 1215 32.84 30.97–34.71 26.04% 0.86 0.79–0.93
Female 284 11.71 10.57–12.85 512 14.9 13.63–16.17 80.28% 1.27 1.12–1.45
M/F Ratio 3.28 2.93–3.65 2.2 1.99–2.43 233%
1
1Male to female (M/F) ratio evolution
doi:10.1371/journal.pone.0018415.t002
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also noted in men aged over 30 years. However, in contrast with
women, the decrease in men is no longer apparent in a regression
analysis that takes into account each year’s data over the two
periods. Thus, it rates in men should be considered as relatively
stable over the period covered by this study. In our analyses, there
was no apparent decrease in liver cancer rates in young subjects
despite the initiation of a vaccination program in 1986 (GHIS). It
should be noted that the introductionof vaccinationin The Gambia
was performed in a stepwise manner during years 1986 to 1990, so
that only half of the subjects born during that period actually
received HB vaccine. Thus, the results presented here cannot be
interpreted as revealing an absence of effect of vaccination in the
younger age group (15–19 years). A recent review of the GHIS has
shown that a significant effect of vaccinationmay not be measurable
before 2017 [1].
A significant decrease over time in male to female ratio for liver
cancer has been observed in the Uganda (Kyadondo) cancer
registry. In this area, the ASR of liver cancer for men is 8.7 per 10
5
person-years and 5.8 for women (ranking 4
th and 8
th among men
and women respectively) [13]. Comparison between the periods
1960–1980 and 1991–2005 showed that liver cancer incidence
(ASR) was quite stable or even slightly decreased among men, but
increased by over 50% among women, with a change in male to
female ratio from 2.32 to 1.30 [14]. Thus, our observations in The
Gambia may correspond to a phenomenon which may also occur
in other Sub-Saharan African countries.
Several explanations may be proposed. First, it is possible that
female liver cancer has been systematically under-detected and
underestimated over earlier cancer registration periods, and that
the increase in the recent period (1998–2006) may primarily reflect
improved registration in women. It should be noted, however, that
no comparable change has been observed for other female cancers
(breast and cervix cancer in particular [5]), hence it is unclear why
there should be a registration bias only for liver cancer. A second
explanation may be changes in the prevalence of liver cancer risk
Figure 2. Male comparative liver cancer trends over two periods of 10 (1988–1997) and 9 (1998–2006) years, by age group.
doi:10.1371/journal.pone.0018415.g002
Figure 3. Female comparative liver cancer trends over two periods of 10 (1988–1997) and 9 (1998–2006) years, by age group.
doi:10.1371/journal.pone.0018415.g003
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gender. Three main factors may be considered: chronic infection
by hepatitis B virus (Hepatitis B Virus), infection by hepatitis C
virus (Hepatitis C Virus) and metabolic conditions associated with
obesity and/or diabetes type 2.
Case control studies have shown that much of the imbalance in
liver cancer incidence between men and women may be attributable
to Hepatitis B Virus. In a study performed between 1997 and 2001,
[10] the prevalence of chronic Hepatitis B Virus carriage was of 18%
in men and 10% in women (p=0.05) with a risk of liver cancer 2.6
(95% CI, [1.5–4.6]) fold higher in men than in women. In contrast,
t h ep r e v a l e n c eo fc h r o n i cH e p a t i t i sCV i r u si n f e c t i o nw a ss i m i l a ri n
both genders (2.6% in males and 3.6% in females, p=0.57). Among
liver cancer patients, 32% of women were Hepatitis C Virus positive,
as compared to 16% of men (p=0.03). Thus, the decrease in male to
female ratio may be suggestive of an increasing impact of Hepatitis C
Virus as cause of liver cancer. The possibility that Hepatitis C Virus
may contribute to the increasing burden of female liver cancer
deserves further investigation.
The other factor that may account for the observed increase in
incidence of liver cancer in female is an increase in the prevalence
of metabolic disorders associated with obesity, physical inactivity
and/or diabetes type 2. Recent meta-analyses have found that in
West Africa, women were more likely to be obese than men (odds
ratio 3.16 95% CI, [2.51–3.98] and 4.79 (95% CI, [3.30–6.95]) in
urban and rural areas, respectively [15]. Time trend analyses
indicated that the prevalence of obesity in urban West Africa had
more than doubled (114%) over 15 years, accounted for almost
entirely in women [15]. Although data are limited, differences in
overweight and obesity by gender and age have been observed in
The Gambia. Among subjects aged 35–50 years (the age group
with high rates of liver cancer), women were more likely to be
overweight or obese as compared to men (34% versus 6%, and
50% versus 6%, respectively) [16]. Cumulative time trends
analyses suggested an increase in the prevalence of diabetes
among adults in urban West Africa, from approximately 3% to 4%
in the past 10 years, with similar prevalence and trends in males
and females [17]. A recent meta-analysis of 11 cohort studies
including cohorts from Western Europe, US and Korea has shown
a substantial association between excess bodyweight and increased
risk of liver cancer. In this meta-analysis, compared with persons
of normal weight, the relative risk of liver cancer was 1.89 (95%
CI: 1.51–2.36) for those who were obese [18]. Although there is
currently no data on West African populations, it is plausible that
overweight may also contribute to the increased burden of liver
cancer in Gambian females. These associations need to be further
tested in case-control and cohort studies.
Our results report a significant association between the risk of
liver cancer and ethnicity. A recent genome-wide association
analysis of malaria in The Gambia demonstrated that self-reported
ethnicity correlates with genetically defined subpopulations [19,20].
Our analyses show that Fula (18% of the population) and Wollof
had a significantly higher risk of liver cancer than Mandinka (42%
of the population). This association was previously reported in a
case-control study in The Gambia [10]. Two studies conducted on
Gambian children reported that blood levels of aflatoxin-albumin
adducts were slightly higher in Fula and Wollof than Mandinka
[21,22]; suggesting that these groups may have a higher sensitivity
to aflatoxin due to genetic polymorphisms in enzymes involved in
aflatoxin metabolism, and detoxification. In a case-control study,
Fula were found to have a significantly higher prevalence than
Mandinka in the Gly399 allele of XRCC1, an enzyme involved in
excision repair of aflatoxin-DNA adducts [23]. These observations
suggest that the higher risk observed in selected groups may be due
to genetic susceptibility, although differences in lifestyle may also
play an important role, in particular among rural populations.
In conclusion, our study based on almost two decades of
population-based cancer registration in The Gambia identifies a
significant trend in increase of hepatocellular carcinoma among
females, with a significant reduction of the male to female ratio.
This observation may be the consequence of changes in lifestyle or
viral risk factors and suggest that recent increase in the prevalence
of obesity among women deserves further attention in hepatocel-
lular carcinoma prevention strategies.
Methods
Liver cancer case definition
The case definition for HepatoCellular Carcinoma (HCC) is
based on a combination of a compatible clinical assessment,
Table 3. Male and female liver cancer by ethnic groups in The Gambia 1998–2006.
Site Ethnic groups
%i nt h e
population Crude Adjusted to district of residence
Rate Ratio CI 95% Rate Ratio CI 95%
Male liver cancer
Mandinka 42 (reference category) - (reference category) -
Fula 18 2.15 1.83–2.53 1.40 1.20–1.65
Wollof 16 1.78 1.50–2.10 1.55 1.31–1.84
Jola 10 1.10 0.87–1.40 0.91 0.71–1.15
Serrahuleh 9 0.61 0.44–0.84 0.73 0.53–1.01
Female liver cancer
Mandinka 42 (reference category) - (reference category) -
Fula 18 1.94 1.51–2.48 1.22 0.95–1.56
Wollof 16 1.80 1.38–2.35 1.37 1.05–1.79
Jola 10 1.29 0.90–1.86 1.19 0.83–1.73
Serrahuleh 9 1.20 0.80–1.81 0.73 0.49–1.11
doi:10.1371/journal.pone.0018415.t003
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nography findings. This definition was assessed against histopa-
thology using a limited number of good quality biopsies obtained
in the course of a case-control study (Szymanska et al., 2003) and
showed a specificity of over 95% for HCC. Clinical assessment
alone showed a specificity over 80%.
Cancer incidence data
Methods and procedures of data collection of the Gambia
National Cancer Registry have been described previously [6].
Data are centralized at the GHIS office in Fajara, verified, and
managed using the CanReg 4.0 software [24] (http://www.iacr.
com.fr/) and ICD-O-3 (international classification of disease for
oncology third edition) for cancer coding. Computerized and
verified data in the Gambia National Cancer Registry was
available until the years 2006. The first two years of cancer
registration (1986 and 1987) were excluded since it was clear that
case finding was incomplete for these two years. The rest of the
available years of cancer registration activity (1988–2006) were
arbitrarily divided into two periods of 9 and 10 years, respectively
(1988–1997 and 1998–2006). Incidence rates for the more recent
period (1998 to 2006) were assessed by gender, age group, years
and ethnicity using the person-years estimates from three
nationwide censuses carried out in 1983, 1993 and 2003.
Population age structure of these censuses were linearly interpo-
lated for period from 1988 to 1992, 1994 to 2002, and
extrapolated for period from 2004 to 2006. Because of the lack
of information concerning ethnicity in the censuses 1983 and
1993, ethnic variation analysis was restricted to the recent period
(1998–2006).
Information on ethnicity
The Gambia population includes about a dozen distinct ethnic
groups, all of which are also present in other countries of West
Africa [25]. Information on ethnicity was self-reported at diagnosis
(each subject identifying him/herself based on the language and
culture of biological parents) or was obtained during a structured
interview by Gambia National Cancer Registry clerks who are
fluent in the language of each major ethnic group. This
information was complete at 87% for men and 86% for women.
Although the variable ‘‘ethnicity’’ captures different sources of
variations including lifestyle, cultural, geographic and possible
genetic factors, a recent genome-wide association analysis of
malaria in the Gambia demonstrated that self-reported ethnicity
correlates with genetically defined subpopulations [26].
Population distributions for the 5 main ethnic groups was based
on the 2003 census in which the Mandinka, Fula, Wollof, Jola and
Serrahuleh represented 42%, 18%, 16%, 10% and 9% of the total
population respectively (http://www.accessgambia.com/informa
tion/people-tribes.html, https://www.cia.gov/library/publications/
the-world-factbook/geos/ga.html#People). In the absence of de-
tailed demographic information, it was assumed that age and sex
population structure in each ethnic group was identical to that of the
whole population. Of note, in the 2003 census, ethnicity was self-
reported.
Statistical analysis
Age standardized incidence rates were obtained by adjusting the
incidence rate to the world population by a 5-year age group as
described by Boyle and Parkin in the book ‘‘enregistrement des
cancers principes et methodes’’ [27]. Joinpoint regression program
version 3.3 (http://srab.cancer.gov/joinpoint/) was used to assess
trends of liver cancer over 19 years (1988–2006). To investigate
ethnic variations in incidence rates (1998–2006 period only),
Poisson regression models were fitted with number of cases as the
response variable and categorical 5-year age group and ethnic
group as explanatory variables. Population size was taken into
account in modelling by using it as an offset term in Poisson
models. All analyses were carried using R software (3). Ethnic
groups have historically distinct geographic distribution in the
country as shown in Table S2. Since access to diagnosis may differ
between urban and rural areas, residence was considered as a
confounding factor. Therefore, incidence rate was adjusted to the
place of residence by stratifying the different ethnic group by place
of residence grouped in district. The adjusted rate ratio was then
obtained by using Mantel and Haenszel’s method as described in
the text book ‘‘Epide ´miologie du cancer principes et me ´thodes
chapter 14’’ [28]. The Mandinka, who represent the most
numerous ethnic group, was used as the reference group.
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